Electromedical Products International, Inc.

Electromedical Products International, Inc. specializes in developing and producing Alpha-Stim electrotherapy devices that provide drug-free relief for anxiety, insomnia, depression, and pain management. Electromedical Products International, Inc. focuses on electrotherapy solutions for mental health and pain management.

Founded in 1981 in Mineral Wells, US, the company has engaged in significant business deals since its inception. The most recent deal occurred in September 2016 when Tillery Capital recapitalized the company, with financial terms undisclosed. Electromedical Products International, Inc. specializes in the development and production of Alpha-Stim electrotherapy devices, designed to provide relief from anxiety, insomnia, depression, and pain in a drug-free manner.

The core product line includes the Alpha-Stim M and Alpha-Stim AID devices, both utilizing microcurrent electrotherapy technology for various conditions. These devices are FDA cleared in the United States for treating anxiety, insomnia, and pain, with additional international approvals for treating depression. The primary users of Alpha-Stim products include individuals with mental health challenges and pain management needs, marketed globally with significant presence in North America, Europe, and other international markets. Electromedical Products International, Inc.

generates revenue through the direct sale of Alpha-Stim devices and accessories via its online store and partnerships with healthcare providers. The business model focuses on direct-to-consumer sales, allowing personal use purchases and bulk orders by healthcare facilities. Specific product pricing has not been disclosed, but the Alpha-Stim M and Alpha-Stim AID devices form the core of the offerings, catering to consumers seeking non-invasive solutions for mental health and pain management. The company emphasizes its commitment to therapeutic solutions that enhance user quality of life, aligning with its focus on innovation in healthcare technology.

Electromedical Products International, Inc. aims to expand its product offerings and geographic reach. Future plans include designing new products targeted at enhancing therapeutic efficacy, with specific release dates to be announced. The company is also exploring expansion into new markets, particularly in Europe and Asia, with a targeted implementation timeline in the next few years.

The recapitalization deal by Tillery Capital in September 2016 will provide the necessary financial resources to support these growth initiatives.